| Dr David Mark Snyderman, DDS | |
|
21 Montauk Ave, Suite 102, New London, CT 06320-4906 | |
| (860) 447-9280 | |
| (860) 437-1938 |
| Full Name | Dr David Mark Snyderman |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 21 Montauk Ave, New London, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316961121 | NPI | - | NPPES |
| 002083335 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 008333 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Mark Snyderman, DDS 15 Applewood Dr, Quaker Hill, CT 06375-1331 Ph: (860) 442-9898 | Dr David Mark Snyderman, DDS 21 Montauk Ave, Suite 102, New London, CT 06320-4906 Ph: (860) 447-9280 |
News Archive
A new compound similar to the active component of marijuana (cannabis) might provide effective pain relief without the mental and physical side effects of cannabis, according to a study in the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.
PBS NewsHour examines how the Canadian organization MEDA is using text messages to track malaria supplies in local clinics and retailers in Tanzania. The piece includes a related video featuring a MEDA employee giving a tour of the program (Cheers, 7/22).
A new position statement issued today by the American Association of Clinical Endocrinologists (AACE) states that women with the Polycystic Ovary Syndrome (PCOS) are at greatest risk for diabetes and coronary artery disease.
AstraZeneca Canada announces the recently approved indication for IRESSA(R), a once-daily oral targeted therapy for the first-line treatment of patients with locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC) who have activating mutations of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK). In conjunction with this approval, AstraZeneca is also announcing the availability of a diagnostic test which can now determine a patient's EGFR mutation status, representing a new era in personalized lung cancer treatment in Canada.
› Verified 4 days ago
Sung Woo Cho, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 258 S Frontage Rd, New London, CT 06320 Phone: 860-437-3462 | |
Teresa Matyas, Dentist Medicare: Not Enrolled in Medicare Practice Location: 4 Shaws Cv Ste 202, New London, CT 06320 Phone: 860-443-4199 | |
Rodcliffe Wint, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 464 Montauk Ave, New London, CT 06320 Phone: 347-575-0520 | |
Dr. Aravind Balagopalan Menon, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 190 Hempstead St, New London, CT 06320 Phone: 860-447-3216 Fax: 860-701-6019 | |
Dr. Christopher Brett Clark, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 190 Hempstead St, New London, CT 06320 Phone: 860-447-3216 Fax: 860-701-6019 | |
Dr. Janellen G Matyas, DDS Dentist Medicare: Medicare Enrolled Practice Location: 4 Shaws Cv Ste 202, New London, CT 06320 Phone: 860-443-4199 Fax: 860-444-6145 | |
Dr. Aman Syed, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 21 Montauk Ave, Suite 102, New London, CT 06320 Phone: 860-447-9280 Fax: 860-437-1938 |